BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12547545)

  • 21. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors.
    Rea D; Delecluse HJ; Hamilton-Dutoit SJ; Marelle L; Joab I; Edelman L; Finet JF; Raphael M
    Ann Oncol; 1994; 5 Suppl 1():113-6. PubMed ID: 8172807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
    Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
    Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
    Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
    Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
    J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL; Tang CG; Bhattacharyya N
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct cellular origins of primary effusion lymphoma with and without EBV infection.
    Hamoudi R; Diss TC; Oksenhendler E; Pan L; Carbone A; Ascoli V; Boshoff C; Isaacson P; Du MQ
    Leuk Res; 2004 Apr; 28(4):333-8. PubMed ID: 15109530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J; Hansmann ML; Rajewsky K; Küppers R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus and Hodgkin's lymphoma.
    Andersson J
    Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-related atypical lymphoproliferative disorders in Waldeyer's ring: a clinicopathological study of 9 cases.
    Kojima M; Nakamura N; Itoh H; Shimizu K; Shimizu K; Matsuda H; Tamaki Y; Masawa N; Nakamura S
    Pathobiology; 2010; 77(4):218-24. PubMed ID: 20616617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
    Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
    Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBV-associated neoplasms: alternative pathogenetic pathways.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Med Hypotheses; 2004; 62(3):387-91. PubMed ID: 14975509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Lisse I; Ralfkiaer E; Sandvej K; Young LS
    J Pathol; 1991 Dec; 165(4):289-99. PubMed ID: 1664459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.